Switzerland · Series B startup

Who invested in Okairos

One round we have observed, with the 2 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Pharma

Funding summaryUpdated 26 Oct 2026

$21Mraised across 1 round since 2010, from 1 source

Latest round
Series B, $21MSept 2010
Investors
2
See who backed them

The rounds

  1. Sept 2010

The exit

ExitBuyerPriceWhen
AcquiredGlaxoSmithKline$325MMay 2013

From historical deal records. Wrong? Tell us.

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Okairos

Who invested in Okairos?

Okairos's investors include Versant Ventures and Boehringer Ingelheim Venture Fund.

How much has Okairos raised?

Okairos has raised $21M across 1 round since 2010.

When did Okairos last raise?

Okairos's most recent round was a Series B of $21M in Sept 2010.

What was Okairos's biggest round?

Its most recent round, $21M in Sept 2010, is also its largest on record.

Who backed Okairos first?

Okairos's first round on record, in Sept 2010, was backed by Versant Ventures and Boehringer Ingelheim Venture Fund.

What stage is Okairos at?

Okairos's latest named round is a Series B, in Sept 2010.

Where is Okairos based?

Okairos is based in Switzerland.

Companies like Okairos

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.